 |
CSA units - Graduate Diploma and Masters Pharmaceutical
Science |
 |
|
|
| Unit
Code |
Unit Title |
Weight |
Sem |
Description |
| CSA234 CSA235 |
Pharmacology |
12.5
12.5 |
1
2 |
Provides an introduction to the study of drugs: chemicals which affect living systems. General principles of drug action and drug disposition, including pharmacokinetics, are outlined. The major part of the unit consists of a detailed account of the major classes of drugs. These include drugs affecting the autonomic nervous system, cardiovascular system and central nervous system; chemical mediators, pain and inflammation; and endocrines. (Chemotherapeutic agents are not covered in this unit). Emphasis is given to therapeutic applications. The practical course gives experience in measuring drug responses in humans. Tutorial topics include ethical issues in animal and human experimentation, and the development and evaluation of new drugs. Coordinator: Dr Yean Yeow Tan |
CSA257
CSA258 |
Pharmaceutical
Science |
12.5
12.5 |
1
2 |
Involves the study of physicochemical principles which are important in the design of dosage forms and other pharmaceutical systems and the application of these principles to practice, particularly in the development of an understanding of the relationship between pharmaceutical formulation and therapeutic activity, including pharmacogenomics. The content of this unit includes physicochemical factors such as dissociation and ionisation, solubility, partitioning, surface activity (including emulsification and solubilisation), decomposition kinetics, adsorption, rheology, micromiretics, and the use of non-oral drug delivery systems. Introduction to the pharmaceutical industry, including pharmacoeconomics and bioinformatics. Coordinator: Dr Glenn Jacobson |
| CSA226 |
Medicinal Chemistry |
12.5 |
2 |
Is the study of chemical structure as a determinant of both the physicochemical properties and biological activity (including metabolic fate) of drug molecules of both synthetic and natural origin. The application of such principles to the design and production of new drug entities is also examined. Coordinator: Dr Stephen Aldous |
| CSA312 |
Clinical
Pharmacokinetics |
12.5 |
2 |
Studies the factors influencing the bioavailability and disposition of drugs, and the application of this information to optimise the therapeutic usefulness of drugs in clinical practice.
Topics include: formulation factors and therapeutic activity; route of administration and bioavailability; developments in drug delivery; estimating drug dosage requirements in clinical practice; therapeutic drug monitoring; drug interactions; an overview of sources of inter-patient variability in pharmacokinetics (eg extremes of age, renal disease, pharmacogenomics); clinical case studies and pharmacokinetics of specific drugs.
Unit objective: to develop a good practical knowledge and understanding of pharmacokinetics through the use of lecture material, practical exercises and problems. A key aim is to develop the ability to logically apply relatively simple pharmacokinetic principles in everyday clinical pharmacy practice. This is achieved through the extensive use of clinically-orientated problems. Coordinator: Professor Greg Peterson |
| CSA332 |
Toxicology |
12.5 |
1 |
CSA332 Toxicology is the study of the harmful effects of chemicals (including drugs) and other agents. Studies cover general principles of toxicology, mechanisms of toxicity, systematic toxicology and toxic agents. Coordinator: Dr Yean Yeow Tan |
GradDipPharmSc M6E:
NOT APPLICABLE FROM 2010
Enrolment codes:
Full time: sem 1: CSA604, sem 2: CSA605 sem 5 (sum): CSA603 Part time: CSA606, CSA607, CSA608, CSA609 |
| CSA421 |
Research
Thesis |
12.5 |
1, 2 |
GradDipPharmSc M6E students undertake the planning and conduct of a research project on a subject of their own choice. This may consist of a drug use review, literature survey or other appropriate activity. Instruction in research design and report writing is given. Coordinator: Dr Stephen Aldous |
MPharmSc M7E:
NOT APPLICABLE FROM 2010
Enrolment codes:
Full time: sem 1: CSA704, sem 2: CSA705 sem 5 (sum): CSA703 Part time: CSA706, CSA707, CSA708, CSA709 |
| CSA444 |
Research Thesis A |
25% |
1 |
MPharmSc M7E students undertake the planning and conduct of a research project on a subject of their own choice. This may consist of a drug use review, literature survey or other appropriate activity. Instruction in research design and report writing is given. A written report of 10,000 words on the project undertaken is required. Coordinator: Dr Glenn Jacobson |
| CSA445 |
Research Thesis B |
25% |
2 |
| CSA446 |
Research Thesis C |
12.5% |
3 |
|
|
 |
|
 |